Efficacy and Safety of Subcutaneous Immunoglobulin in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of RCTs

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

Subcutaneous Immunoglobulin (IgPro20) Dose Adjustments for Chronic Inflammatory Demyelinating Polyneuropathy Maintenance Therapy in Clinical Practice

Treatment Impact of Efgartigimod PH20 SC on I-RODS Daily Activity Assessment in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Post Hoc Analysis of the Registrational ADHERE Study